OLD Mission Capital LLC acquired a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,073 shares of the pharmacy operator’s stock, valued at approximately $210,000.
A number of other institutional investors also recently bought and sold shares of the stock. Bank of New York Mellon Corp increased its holdings in Walgreens Boots Alliance by 71,970.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock worth $848,617,000 after buying an additional 11,624,703 shares in the last quarter. FMR LLC increased its holdings in Walgreens Boots Alliance by 41.9% in the 3rd quarter. FMR LLC now owns 5,640,694 shares of the pharmacy operator’s stock worth $411,206,000 after buying an additional 1,665,402 shares in the last quarter. Shell Asset Management Co. increased its holdings in Walgreens Boots Alliance by 8.0% in the 3rd quarter. Shell Asset Management Co. now owns 144,009 shares of the pharmacy operator’s stock worth $10,498,000 after buying an additional 10,647 shares in the last quarter. Westpac Banking Corp increased its holdings in Walgreens Boots Alliance by 91.2% in the 3rd quarter. Westpac Banking Corp now owns 113,470 shares of the pharmacy operator’s stock worth $8,272,000 after buying an additional 54,110 shares in the last quarter. Finally, D.A. Davidson & CO. increased its holdings in Walgreens Boots Alliance by 1.5% in the 3rd quarter. D.A. Davidson & CO. now owns 79,545 shares of the pharmacy operator’s stock worth $5,799,000 after buying an additional 1,178 shares in the last quarter. 63.07% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts have issued reports on the company. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Monday, March 11th. Loop Capital downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating and cut their price target for the company from $77.00 to $60.00 in a research note on Wednesday, April 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, February 14th. Robert W. Baird cut their price target on Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating for the company in a research note on Friday, March 1st. Finally, UBS Group began coverage on Walgreens Boots Alliance in a research report on Thursday, January 17th. They set a “sell” rating and a $70.00 price objective on the stock. Five research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $68.50.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). The company had revenue of $34.53 billion for the quarter, compared to the consensus estimate of $34.57 billion. Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.73 EPS. As a group, equities analysts predict that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.
In related news, COO Ornella Barra bought 18,000 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were purchased at an average price of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now owns 26,425 shares in the company, valued at approximately $1,441,748. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
See Also: Understanding Options Trading
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.